Kenneth Hinds is a notable inventor based in Fort Collins, CO (US). He has made significant contributions to the field of biochemistry, particularly in the development of protein-polymer conjugates. With a total of 3 patents, Hinds has focused on innovative methods that enhance the efficacy of pharmaceutical formulations.

Latest Patents

Hinds' latest patents include groundbreaking work on site-specific insulin-polymer conjugates. This invention is directed to a single-step method for rapidly and efficiently preparing protein-polymer conjugates, including an insulin-polymer conjugate. The method involves contacting a protein and hydrophilic polymer in the presence of at least one organic solvent and at least one metal chelator. This process promotes the formation of a conjugate of the protein and polymer. The invention emphasizes the site-specific modification of selected proteins, such as insulin, with poly(ethylene glycol) at residue PheB1. Additionally, it provides a pharmaceutical formulation for encapsulating the conjugate in a biodegradable polymer.

Career Highlights

Throughout his career, Kenneth Hinds has worked with various companies, including Antriabio, Inc. and Pr Pharmaceuticals, Inc. His work has significantly impacted the development of innovative pharmaceutical solutions.

Collaborations

Hinds has collaborated with notable individuals in his field, including Danny H Lewis and Paul J Schmidt. These collaborations have furthered his research and development efforts in protein-polymer conjugates.

Conclusion

Kenneth Hinds is a distinguished inventor whose work in protein-polymer conjugates has the potential to revolutionize pharmaceutical formulations. His innovative methods and collaborations highlight his commitment to advancing biochemistry and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.